DOJ - G2 Intelligence

September 2024 Labs in Court

Recent DOJ settlements continue to focus on issues involving medical necessity and marketer compensation

Start a Free Trial for immediate access to this article

Already a member? Log in here

Lab leaders should be wary of telemedicine arrangements, certain marketing firms, and unnecessary PGx and CGx testing

Start a Free Trial for immediate access to this article

Already a member? Log in here

Recent cases involve another fraud related to finger prick blood testing, as well as alleged malpractice and discrimination.

Start a Free Trial for immediate access to this article

Already a member? Log in here

Recent cases involve charges and judgments related to COVID-19 add-on tests, genetic testing fraud, and kickbacks.

Start a Free Trial for immediate access to this article

Already a member? Log in here

Proposed rule would require businesses to undergo even more stringent review to secure regulatory approval for such deals.

Start a Free Trial for immediate access to this article

Already a member? Log in here